Basic Information
Basic information for MIR646HG-261-69aa
Peptide Name MIR646HG-261-69aa
Genome Position chr20:60559691-60559897[+]
Species Human
Peptide Sequence MCGRLAGCCLSSSTWHLLSTCLWLECRVPEETLQVKLNHPRTLENHHCDGPTLVPSDIVSCSRIAFSKA
Peptide Length 69
Unique No (MIR646HG-266-69aa,MIR646HG-267-69aa)
Grand Average of Hydropathicity 0.029
Relative Molecular Mass 8878.05
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000228340;MIR646HG
Transcript ID/Name ENST00000665114;MIR646HG-261
Transcript Length 1250
Coding Ability 0.512
DNA Sequence Corresponding to Peptide ATGTGTGGCCGCCTGGCCGGCTGCTGTCTTAGTTCCTCCACGTGGCACTTGTTGAGCACCTGTCTCTGGCTGGAATGCCGGGTGCCAGAAGAAACTCTGCAAGTAAAACTCAACCATCCCAGGACACTGGAAAATCACCACTGTGATGGGCCAACTCTGGTTCCCAGTGACATTGTAAGTTGCTCCCGAATCGCCTTTTCCAAGGCT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :